Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for High-risk gestational trophoblastic neoplasia (FIGO score 7 or more, including ultra-high-risk), drawn from the whole corpus: 0 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Nothing recorded in development for this cancer yet.
EMA-CO has never been tested against any other regimen in a randomised trial.
Late diagnosis of choriocarcinoma after term pregnancy still costs lives.
Nothing recorded yet.
Nothing recorded yet.
Also on OnCo: Symptoms and red flags · Early detection roadmap.
Etoposide raises the long-term risk of leukaemia and its dose cannot easily be reduced.
Where checkpoint inhibitors belong in the sequence is being worked out from small series.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 7 changes by month →When this page itself was last checked or edited.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.